AgomAb Therapeutics NV (AGMB)
12.08
+0.67
(+5.87%)
USD |
NASDAQ |
Sep 17, 16:00
12.01
-0.07
(-0.58%)
After-Hours: 20:00
AgomAb Therapeutics Price to Book Value : 3.830 for Sept. 17, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 17, 2026 | 3.830 |
| September 16, 2026 | 3.617 |
| September 15, 2026 | 3.855 |
| September 14, 2026 | 3.893 |
| September 11, 2026 | 4.140 |
| September 10, 2026 | 4.419 |
| September 09, 2026 | 4.742 |
| September 08, 2026 | 4.727 |
| September 04, 2026 | 5.002 |
| September 03, 2026 | 4.701 |
| September 02, 2026 | 4.330 |
| September 01, 2026 | 4.292 |
| August 31, 2026 | 4.175 |
| August 28, 2026 | 4.175 |
| August 27, 2026 | 4.388 |
| August 26, 2026 | 4.527 |
| August 25, 2026 | 4.444 |
| August 24, 2026 | 4.064 |
| August 21, 2026 | 4.200 |
| August 20, 2026 | 4.258 |
| August 19, 2026 | 4.359 |
| August 18, 2026 | 4.353 |
| August 17, 2026 | 4.337 |
| August 14, 2026 | 4.191 |
| August 13, 2026 | 4.421 |
| Date | Value |
|---|---|
| August 12, 2026 | 4.473 |
| August 11, 2026 | 4.708 |
| August 10, 2026 | 4.755 |
| August 07, 2026 | 4.597 |
| August 06, 2026 | 4.280 |
| August 05, 2026 | 4.540 |
| August 04, 2026 | 4.670 |
| August 03, 2026 | 4.286 |
| July 31, 2026 | 4.08 |
| July 30, 2026 | 4.044 |
| July 29, 2026 | 3.931 |
| July 28, 2026 | 3.975 |
| July 27, 2026 | 3.966 |
| July 24, 2026 | 3.966 |
| July 23, 2026 | 4.112 |
| July 22, 2026 | 3.677 |
| July 21, 2026 | 3.69 |
| July 20, 2026 | 3.798 |
| July 17, 2026 | 3.817 |
| July 16, 2026 | 3.906 |
| July 15, 2026 | 4.004 |
| July 14, 2026 | 3.817 |
| July 13, 2026 | 3.902 |
| July 10, 2026 | 4.146 |
| July 09, 2026 | 4.131 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cocrystal Pharma, Inc. | 15.06 |
| CNBX Pharmaceuticals, Inc. | -- |
| GB Sciences, Inc. | -- |
| Invion Ltd. | -- |
| Arvinas, Inc. | 0.9652 |
Price to Book Value Related Metrics
| Price | 12.08 |
| Earnings Yield | -5.57% |
| Market Cap | 594.92M |